Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01187472 · ClinicalTrials.gov registry record
Organ Preservation in the Multispeciality Therapy of Stage II-IV Locally Advanced Head and Neck Cancer
A clinical trial, sponsored by University of Chicago.
- Completed
- Registry status
- 35
- Enrollment target
NCT01187472 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 35 participants.
The verdict
NCT01187472 has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
This protocol was opened to collect long term survival information on subjects enrolled in a previous study which evaluated the impact of neoadjuvant chemotherapy and concomitant chemoradiotherapy with organ preserving optional surgery on overall survival, time to progression, pattern of disease recurrence in patient with locally advanced head and neck cancer. The last surviving subject was last treated in 1989, and was lost to follow up in 2010.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2003-03 |
| Est. Completion | 2010-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01187472
The ClinicalTrials.gov registry entry for NCT01187472 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01187472 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01187472 about?
NCT01187472 is a clinical study titled "Organ Preservation in the Multispeciality Therapy of Stage II-IV Locally Advanced Head and Neck Cancer". This protocol was opened to collect long term survival information on subjects enrolled in a previous study which evaluated the impact of neoadjuvant chemotherapy and concomitant chemoradiotherapy with organ preserving optional surgery on overall survival, time to progression, pattern of disease rec...
What is the current status of trial NCT01187472?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2003-03. Estimated completion is 2010-12.
Who is sponsoring clinical trial NCT01187472?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.